Research interests
Cardiac Implantable Electronic Device Infection: Nationwide Trends in Extraction Utilization and In-Hospital Outcomes.[8]
Albert C Lin
Fellowship at University of Chicago Hospitals
As of 1999 · Last known relationship
Fellowship at University of Chicago Hospitals
As of 1999 · Last known relationship
Albert C. Lin is an associate professor of Medicine in Cardiology at Northwestern University Feinberg School of Medicine and leads the active LAAOS-4 clinical trial. His public clinical and research work focuses on left atrial appendage closure, atrial fibrillation, cardiac implantable electronic devices, lead management, and cardiac electrophysiology. Lin earned his MD from the University of Chicago in 1992 and completed residency and fellowships at University of Chicago Hospitals in 1995, 1998, and 1999. He is board certified in Clinical Cardiac Electrophysiology and Cardiovascular Disease and has been a Fellow of the American College of Cardiology since 2001 and the Heart Rhythm Society since 2015. Earlier, at the University of Chicago Medical Center, he implanted the first Attain Ability cardiac lead on April 23, 2009.
Implanted the first Attain Ability cardiac lead on April 23, 2009
Each topic is linked to its supporting source in Sources.
Training includes Fellowship at University of Chicago Hospitals, Residency at University of Chicago Hospitals, MD from the University of Chicago, and Associate Professor, Medicine (Cardiology), plus 4 more records.
Explore education and trainingAs of 1999
As of 1998
As of 1995
As of 1992
Cardiac Implantable Electronic Device Infection: Nationwide Trends in Extraction Utilization and In-Hospital Outcomes.[8]
Effect of Left Atrial Size and Volume Reduction on Pulmonary Vein Isolation Efficacy in Patients With Persistent and Longstanding Persistent Atrial Fibrillation: Subset Analysis From the aMAZE Trial.[8]
REview and improvement of cardiac implanTable device Infection management qualitY initiative (RECTIFY): Rationale and design for a cardiac implantable electronic device infection quality initiative demonstration project.[8]
Secondary Cardiac Lymphoma Causing High-Grade Heart Block: Pacemaker Considerations in an Unpredictable Clinical Course.[8]